Sijmen de Vries
Chief Executive Officer bei PHARMING GROUP N.V.
Vermögen: 9 Mio $ am 31.03.2024
Profil
Dr. Sijmen de Vries is an Independent Non-Executive Director at Biodexa Pharmaceuticals Plc, a Chief Executive Officer & Executive Director at Pharming Group NV, a Chief Executive Officer at Pharming Intellectual Property BV and a Finish Partner at BioConnection BV.
He is on the Board of Directors at Biodexa Pharmaceuticals Plc, Pharming Group NV and Sylus Pharmaceuticals Ltd.
Dr. de Vries was previously employed as a Non-Executive Director by Midatech Ltd., a Chief Executive Officer by 4-Antibody AG, and a Chief Executive Officer by Morphochem AG.
He received his MBA from Ashridge Business School and a doctorate degree from the University of Amsterdam.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PHARMING GROUP NV
1,27% | 31.03.2024 | 8 544 736 ( 1,27% ) | 9 Mio $ | 31.03.2024 |
| 17.04.2023 | 1 322 ( 0,00% ) | 0 $ | 31.01.2024 |
Aktive Positionen von Sijmen de Vries
| Unternehmen | Position | Beginn |
|---|---|---|
| PHARMING GROUP N.V. | Chief Executive Officer | 13.10.2008 |
| BIODEXA PHARMACEUTICALS PLC | Director/Board Member | 29.10.2014 |
| Sylus Pharmaceuticals Ltd. | Director/Board Member | 21.06.2010 |
Pharming Intellectual Property BV
 Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Part of Pharming Group NV, Pharming Intellectual Property BV manufactures milking equipment. The private company is based in Leiden, Netherlands. The CEO of the Dutch company is Sijmen de Vries. | Chief Executive Officer | - |
BioConnection BV
 BioConnection BV BiotechnologyHealth Technology BioConnection BV manufactures and develops injectable pharmaceutical products. Its services include fill & finish, freeze drying, clinical trial material services, project management and consultancy services. The company was founded in 2005 and is headquartered in Oss, the Netherlands. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Sijmen de Vries
| Unternehmen | Position | Ende |
|---|---|---|
Midatech Ltd.
 Midatech Ltd. BiotechnologyHealth Technology Midatech Ltd. engages in research and experimental development on biotechnology services. The company is headquartered in Abingdon, the United Kingdom. | Director/Board Member | 13.03.2015 |
4-Antibody AG
 4-Antibody AG Pharmaceuticals: MajorHealth Technology 4-Antibody AG was discovers and develops drugs. The company was founded in 2002 and headquartered in Basel, Switzerland. | Chief Executive Officer | - |
Morphochem AG
 Morphochem AG Miscellaneous Commercial ServicesCommercial Services Morphochem AG discovers and develops drugs. It focuses on finding therapeutic agents to treat cancer, anti-infectives, inflammation, metabolic disorders and infectious diseases, with particular emphasis on enzyme inhibitors. The company has developed an integrated chemical genomics drug discovery engine that it is applying in third party research programs and for building its own fully owned pipeline. Morphochem is headquartered in Munich, Germany. | Chief Executive Officer | - |
Ausbildung von Sijmen de Vries
| University of Amsterdam | Doctorate Degree |
| Ashridge Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PHARMING GROUP N.V. | Health Technology |
| BIODEXA PHARMACEUTICALS PLC | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Morphochem AG
Morphochem AG Miscellaneous Commercial ServicesCommercial Services Morphochem AG discovers and develops drugs. It focuses on finding therapeutic agents to treat cancer, anti-infectives, inflammation, metabolic disorders and infectious diseases, with particular emphasis on enzyme inhibitors. The company has developed an integrated chemical genomics drug discovery engine that it is applying in third party research programs and for building its own fully owned pipeline. Morphochem is headquartered in Munich, Germany. | Commercial Services |
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology 4-Antibody AG was discovers and develops drugs. The company was founded in 2002 and headquartered in Basel, Switzerland. | Health Technology |
BioConnection BV
BioConnection BV BiotechnologyHealth Technology BioConnection BV manufactures and develops injectable pharmaceutical products. Its services include fill & finish, freeze drying, clinical trial material services, project management and consultancy services. The company was founded in 2005 and is headquartered in Oss, the Netherlands. | Health Technology |
Midatech Ltd.
Midatech Ltd. BiotechnologyHealth Technology Midatech Ltd. engages in research and experimental development on biotechnology services. The company is headquartered in Abingdon, the United Kingdom. | Health Technology |
| Sylus Pharmaceuticals Ltd. | |
Pharming Intellectual Property BV
Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Part of Pharming Group NV, Pharming Intellectual Property BV manufactures milking equipment. The private company is based in Leiden, Netherlands. The CEO of the Dutch company is Sijmen de Vries. | Producer Manufacturing |
